Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 26.581\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. N#Cc1cn(CC(=O)O)c2ccccc12
b. O=C(OC1CN2CCC1CC2)c1ccc(Cl)cc1
c. Cn1c(N)c(-c2nc3cccnc3n2C)sc1=S
d. Cc1c(C(=O)NCCCN2CCOCC2)oc2c1C1(CCC2)SCCS1
Answer: c. Cn1c(N)c(-c2nc3cccnc3n2C)sc1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(N)c(-c2nc3cccnc3n2C)sc1=S
Cn1c(N)c(-c2nc3cccnc3n2C)sc1=S
4-amino-3-methyl-5-(3-methylimidazo[4,5-b]pyridin-2-yl)-1,3-thiazole-2-thione